Australian and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, South Australia, Australia.
Department of Nephrology, Monash Children's Hospital, Clayton, Victoria, Australia.
Nephrology (Carlton). 2021 Sep;26(9):715-724. doi: 10.1111/nep.13886. Epub 2021 May 10.
Cardiovascular death is a leading cause of mortality in paediatric end-stage kidney disease (ESKD). There is however little known about the clinically relevant vascular disease in this population. We aimed to describe the incidence of new onset vascular disease and vascular death in Australian children receiving renal replacement therapy (RRT). We also aimed to identify demographic or childhood risk factors for these endpoints, and whether vascular disease predicts mortality.
Data on Australian patients who commenced RRT at <18 years of age from 1991 to 2017 were extracted from the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA). Multivariable competing risks regression was used to identify factors associated with vascular events.
A cohort of 1268 patients were followed up for a median of 10.31 years. Vascular disease was reported in 5.4%, and vascular death in 4.1%. The cumulative incidence of any vascular event, that is, disease or death, at 10 and 20 years was 5.5% and 12.8%, respectively. Childhood vascular events were associated with non-Caucasian, non-Indigenous ethnicity, and for the 804 patients followed up after 18 years of age, vascular events were associated with lack of childhood transplantation, longer childhood dialysis duration and Indigenous ethnicity. Vascular disease was only reported for 25.49% of patients who had a vascular death, and although a significant risk factor for mortality, it had limited ability to predict mortality.
Cumulative incidence of vascular events is significant after commencing RRT during childhood and is associated with ethnicity, longer childhood dialysis duration and lack of childhood transplantation.
心血管死亡是儿科终末期肾病(ESKD)患者死亡的主要原因。然而,人们对该人群中临床相关血管疾病知之甚少。我们旨在描述澳大利亚接受肾脏替代治疗(RRT)的儿童中新发血管疾病和血管死亡的发生率。我们还旨在确定这些终点的人口统计学或儿童期危险因素,以及血管疾病是否可预测死亡率。
从 1991 年至 2017 年,从澳大利亚和新西兰透析和移植登记处(ANZDATA)提取了在 18 岁以下开始接受 RRT 的澳大利亚患者的数据。使用多变量竞争风险回归来确定与血管事件相关的因素。
对 1268 例患者进行了中位 10.31 年的随访。报告了 5.4%的血管疾病和 4.1%的血管死亡。任何血管事件(即疾病或死亡)的累积发生率在 10 年和 20 年分别为 5.5%和 12.8%。儿童期血管事件与非白种人、非土著民族有关,对于 804 例在 18 岁后接受随访的患者,血管事件与儿童期未接受移植、儿童期透析时间延长和土著民族有关。仅有 25.49%的发生血管死亡的患者报告有血管疾病,尽管它是死亡的显著危险因素,但对死亡率的预测能力有限。
在儿童时期开始接受 RRT 后,血管事件的累积发生率很高,与种族、儿童期透析时间延长和儿童期未移植有关。